Bottom line, the LPC funding is controlled, at the market selling of shares by the company. It did not negatively impact the price of the stock the last time it was used.
Appreciate your opinion. The Rett Foundation's funding of A2-73's Rett trial has been stated I believe to be a "minimum" of $600K. This will likely be the shortest trial, stated to be 3 months, with potentially early read-outs for certain end-points such as seizures. If positive this may "move" the stock and make funding easier in various ways. However I realize that my opinion at this point is based on hope, not fact. Probably why I'm not the best investor.
Market Data 
Markets 
AI
